Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Infiniwell is a digital health company specializing in AI-powered remote patient monitoring and diagnostic solutions, primarily focused on cardiology. The company's flagship platform, Sentio, utilizes advanced algorithms to analyze ECG data in real-time, enabling early detection of arrhythmias and other cardiac conditions. By integrating wearable sensors with cloud-based AI, Infiniwell provides healthcare providers with actionable insights for chronic disease management and post-acute care. Their technology aims to improve patient outcomes while reducing the burden on clinical staff through automated triage and reporting. The platform is designed to be device-agnostic, allowing for seamless integration with various medical-grade wearables.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Infiniwell.